Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.61
BATS BZX Real-Time Price
As of 3:40pm ET
 -0.23 / -0.56%
Today’s Change
37.20
Today|||52-Week Range
44.54
+5.45%
Year-to-Date

Today’s Trading

Previous close40.84
Today’s open40.69
Day’s range40.60 - 40.84
Volume268,952
Average volume (3 months)3,020,885
Market cap$100.4B
Dividend yield4.99%
Data as of 3:40pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.87%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+2.85%
P/E ratio51.6
Price/Sales2.52
Price/Book71.56

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.54-0.84%
NVONovo Nordisk-0.22-0.44%
CELGCelgene+1.20+0.99%
ABTAbbott Laboratories-0.21-0.37%
Data as of 3:40pm ET, 10/23/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.83
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts